Infleqtion (NASDAQ: INFQ) CEO awarded major option and stock grants
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Infleqtion, Inc.’s Chief Executive Officer and director Matthew John Kinsella reported multiple equity awards dated February 13, 2026. He received a stock option for 5,950,380 shares and another option for 481,727 shares, both granted at an exercise price of $0.00 per share. Some of these options vest monthly, with a portion accelerated at the closing of prior mergers, and legacy ColdQuanta options were converted into Infleqtion options on the same terms. Kinsella also reported indirect acquisitions of common stock awards of 560,327, 34,740 and 101,882 shares, held through Kinsella Investment Holdings, LLC and two John R. Kinsella family trusts over which he has voting and investment power.
Positive
- None.
Negative
- None.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Kinsella Matthew John
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 5,950,380 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 1,889,829 | $0.00 | -- |
| Grant/Award | Stock Option (Right to Buy) | 481,727 | $0.00 | -- |
| Grant/Award | Common Stock | 560,327 | $0.00 | -- |
| Grant/Award | Common Stock | 34,740 | $0.00 | -- |
| Grant/Award | Common Stock | 101,882 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 5,950,380 shares (Direct);
Stock Option (Right to Buy) — 1,889,829 shares (Indirect, See footnote);
Common Stock — 560,327 shares (Indirect, See footnote)
Footnotes (1)
- Received pursuant to the Agreement and Plan of Merger and Reorganization, dated as of September 8, 2025, by and among Churchill Capital Corp X, a Delaware corporation now known as Infleqtion, Inc. ("Acquiror"), AH Merger Sub I, Inc., a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub I"), AH Merger Sub II, LLC, a direct, wholly-owned Subsidiary of Acquiror ("Merger Sub II" and together with Merger Sub I, "Merger Subs") and ColdQuanta, Inc. (the "Company") pursuant to which (a) Merger Sub I was merged with and into the Company, and the Company continued as the surviving corporation and immediately thereafter, (b) the Company merged with and into Merger Sub II, and Merger Sub II became the surviving company and continued in existence as a wholly-owned subsidiary of Acquiror (collectively, the "Mergers"). In connection with the Mergers, Acquiror changed its name to Infleqtion, Inc. (the "Issuer"). Held directly by Kinsella Investment Holdings, LLC. Mr. Kinsella may be deemed to beneficially own shares of Kinsella Investment Holdings, LLC by virtue of his voting power and investment power over such shares. Held directly by The John R. Kinsella Children's Trust, of which the Reporting Person is co-trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Children's Trust by virtue of his voting power and investment power over such shares. Held directly by The John R. Kinsella Revocable Living Trust, of which the Reporting Person is a trustee. Mr. Kinsella may be deemed to beneficially own shares of The John R. Kinsella Revocable Living Trust by virtue of his voting power and investment power over such shares. 25% of the stock option vested and became exercisable on April 5, 2025, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. 2,275,146 of such shares accelerated and vested upon the closing of the Mergers. The option may be early exercised by the Reporting Person. Pursuant to the Mergers, the legacy stock options of the Company were automatically converted into the right to receive stock options of the Issuer with the same terms and conditions. Fully vested. 1/48th of the shares underlying the option vest in equal monthly installments commencing on February 17, 2026, subject to the Reporting Person's continued service through each vesting date.
FAQ
What insider transactions did Infleqtion (INFQ) report for Matthew John Kinsella?
Infleqtion CEO Matthew John Kinsella reported equity award acquisitions, not open-market trades. He received large stock option grants and indirect common stock awards as part of compensation and merger-related conversions, with no cash purchase price disclosed in the filing.
How many stock options were granted to the Infleqtion CEO in this Form 4?
The CEO was granted a stock option for 5,950,380 shares and a separate option for 481,727 shares. Both options have a stated exercise price of $0.00 per share, reflecting award terms rather than a market transaction price.
What are the key vesting terms of Matthew Kinsella’s Infleqtion stock options?
One option vested 25% on April 5, 2025, then vests 1/48th monthly until fully vested, with 2,275,146 shares accelerating at the merger closing. Another option vests 1/48th monthly starting February 17, 2026, conditioned on continued service.
Were legacy ColdQuanta options converted into Infleqtion (INFQ) options?
Yes. Legacy ColdQuanta stock options were automatically converted into Infleqtion options in the merger. The filing states they carry the same terms and conditions as before, preserving vesting and other award features through the corporate reorganization.
What indirect holdings are reported for the Infleqtion CEO in this Form 4?
Indirect holdings include common stock awards of 560,327, 34,740 and 101,882 shares. These are held through Kinsella Investment Holdings, LLC and two John R. Kinsella family trusts, where Matthew Kinsella has voting and investment power and may be deemed a beneficial owner.